• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?

作者信息

De Rosa Francesco Giuseppe, Corcione Silvia, Montrucchio Giorgia, Brazzi Luca, Di Perri Giovanni

机构信息

Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.

Department of Surgical Sciences, Division of Anesthesia and Critical Care, City of Science and Health, Molinette Hospital, University of Turin, Italy.

出版信息

Turk J Anaesthesiol Reanim. 2016 Dec;44(6):279-282. doi: 10.5152/TJAR.2016.0011. Epub 2016 Dec 1.

DOI:10.5152/TJAR.2016.0011
PMID:28058136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5207413/
Abstract
摘要

相似文献

1
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?重症监护病房侵袭性念珠菌病的恰当治疗：时机、定植指数、念珠菌评分及生物标志物，走向降阶梯治疗？
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):279-282. doi: 10.5152/TJAR.2016.0011. Epub 2016 Dec 1.
2
Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.Épico项目。运用德尔菲技术制定关于非中性粒细胞减少的成年危重症患者侵袭性念珠菌病的教育建议。
Rev Iberoam Micol. 2013 Jul-Sep;30(3):135-49. doi: 10.1016/j.riam.2013.05.006. Epub 2013 May 29.
3
Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.念珠菌生物标志物和DNA检测对重症腹部疾病ICU患者侵袭性念珠菌病诊断的贡献。
Crit Care. 2016 May 16;20(1):149. doi: 10.1186/s13054-016-1324-3.
4
[Determination of Candida colonization and Candida score in patients in anesthesia intensive care unit].[麻醉重症监护病房患者念珠菌定植及念珠菌评分的测定]
Mikrobiyol Bul. 2016 Jul;50(3):438-48. doi: 10.5578/mb.27685.
5
[Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].[Épico项目：运用德尔菲技术制定非中性粒细胞减少的成年危重症患者侵袭性念珠菌病的教育建议。Épico项目组]
Rev Iberoam Micol. 2013 Jul-Sep;30(3 Suppl 1):135-49. doi: 10.1016/j.riam.2013.05.005. Epub 2013 Jun 11.
6
Is Candida really a threat in the ICU?念珠菌在重症监护病房真的构成威胁吗？
Curr Opin Crit Care. 2008 Oct;14(5):600-4. doi: 10.1097/MCC.0b013e32830f1dff.
7
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.抗真菌药物降级治疗与接受侵袭性念珠菌病治疗的危重症患者的不良结局无关：AmarCAND2 研究数据的事后分析。
Intensive Care Med. 2015 Nov;41(11):1931-40. doi: 10.1007/s00134-015-4053-1. Epub 2015 Sep 14.
8
ÉPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.ÉPICO项目。运用德尔菲技术制定针对非中性粒细胞减少的成年危重症患者侵袭性念珠菌病的教育建议。
Rev Esp Anestesiol Reanim. 2013 Aug-Sep;60(7):e1-e18. doi: 10.1016/j.redar.2013.05.016. Epub 2013 Aug 2.
9
Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients.口服制霉菌素预防危重症机械通气患者念珠菌属定植
Intensive Care Med. 2005 Nov;31(11):1508-13. doi: 10.1007/s00134-005-2807-x. Epub 2005 Sep 30.
10
External Validation of Risk Prediction Scores for Invasive Candidiasis in a Medical/Surgical Intensive Care Unit: An Observational Study.内科/外科重症监护病房侵袭性念珠菌病风险预测评分的外部验证：一项观察性研究
Indian J Crit Care Med. 2017 Aug;21(8):514-520. doi: 10.4103/ijccm.IJCCM_33_17.

引用本文的文献

1
A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.重症监护病房内新型冠状病毒肺炎相关肺曲霉病（CAPA）的区域观察性研究：试图打破常规。
J Fungi (Basel). 2022 Nov 30;8(12):1264. doi: 10.3390/jof8121264.
2
Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score.重症监护病房中耐碳青霉烯类病原体引起的血流感染：危险因素分析及预后评分建议
Pathogens. 2022 Jun 23;11(7):718. doi: 10.3390/pathogens11070718.
3
Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach.基于EPIC III（重症监护病房感染扩展患病率）方法的重症监护病房感染主动持续监测项目的有效性。
J Clin Med. 2022 Apr 28;11(9):2482. doi: 10.3390/jcm11092482.
4
A Letter in Response to "Diagnosing Catheter-Associated Urinary Tract Infection in Critically ill Patients: Do the Guidelines Help?".
Indian J Crit Care Med. 2018 Jun;22(6):467-468. doi: 10.4103/ijccm.IJCCM_225_18.
5
Epidemiological Study on Species in Patients with Cancer in the Intensive Care Unit.重症监护病房癌症患者的物种流行病学研究。
Osong Public Health Res Perspect. 2017 Dec;8(6):384-388. doi: 10.24171/j.phrp.2017.8.6.05. Epub 2017 Dec 31.

本文引用的文献

1
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.ICU 获得性败血症、假丝酵母菌定植和多器官功能衰竭患者中经验性米卡芬净治疗与侵袭性真菌感染的生存：EMPIRICUS 随机临床试验。
JAMA. 2016 Oct 18;316(15):1555-1564. doi: 10.1001/jama.2016.14655.
2
Antifungal stewardship considerations for adults and pediatrics.成人和儿科抗真菌药物管理的考虑因素。
Virulence. 2017 Aug 18;8(6):658-672. doi: 10.1080/21505594.2016.1226721. Epub 2016 Sep 2.
3
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.基于（1,3）-β-D-葡聚糖的抗真菌治疗用于念珠菌血症高危的危重症成人：一项观察性研究。
J Antimicrob Chemother. 2016 Aug;71(8):2262-9. doi: 10.1093/jac/dkw112. Epub 2016 Apr 28.
4
The paradox of the evidence about invasive fungal infection prevention.侵袭性真菌感染预防证据的悖论。
Crit Care. 2016 Apr 27;20(1):114. doi: 10.1186/s13054-016-1284-7.
5
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.用于预防非中性粒细胞减少的重症患者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3.
6
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
7
The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].内科病房念珠菌血症中氟康唑或棘白菌素治疗对死亡率的影响[已修正]
PLoS One. 2015 May 4;10(5):e0125149. doi: 10.1371/journal.pone.0125149. eCollection 2015.
8
Preventing invasive candida infections. Where could we do better?预防侵袭性念珠菌感染。我们在哪些方面可以做得更好？
J Hosp Infect. 2015 Apr;89(4):302-8. doi: 10.1016/j.jhin.2014.11.006. Epub 2014 Dec 16.
9
Incidence, characteristics and outcome of ICU-acquired candidemia in India.印度 ICU 获得性念珠菌血症的发生率、特征和结局。
Intensive Care Med. 2015 Feb;41(2):285-95. doi: 10.1007/s00134-014-3603-2. Epub 2014 Dec 16.
10
Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later.危重症外科患者的念珠菌定植指数及随后的感染：20年后
Intensive Care Med. 2014 Oct;40(10):1429-48. doi: 10.1007/s00134-014-3355-z. Epub 2014 Jun 17.